Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis

<div>Forest plot of the odds of VTE in ovarian cancer patients that have clear cell carcinoma histology (versus nonclear cell carcinoma). This figure shows the pooled odd of clear cell carcinoma histology (versus nonclear cell carcinoma). The total pooled odds are 2.11 (1.55-2.89).</div>

Obstetrics and Gynecology International

fig4

Figure 4

Figure 4: Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis 